Study to determine if a DNA-based blood test can help detect

The Children’s Tumor Foundation (CTF) has announced a groundbreaking 3-year study, which it will fund for nearly $2 million, to determine if a DNA-based blood test can offer better understanding and ultimately earlier diagnosis of cancer predisposition in neurofibromatosis type 1 (NF1) patients.

Related Keywords

Annette Bakker , Angela Hirbe , Jack Shern , Emily Henderson , John Shern , Washington University , National Cancer Institute , Department Of Defense , National Institutes Of Health , Research Programs , Nf Clinical Trials Consortium , Children Tumor Foundation , Tumor Foundation , Principal Investigators , National Institutes , Aadel Chaudhuri , Idea Award , Discovery Industry Focus , Capitol Hill , Biomarker , Dancer , Flood , Blood Test , Children , Na , Alignant , Medical Research , Nerve , Neurofibromatosis , Research , Humor ,